Aspen Pharmacare negotiating to produce mpox vaccines

marketscreener.com

Aspen Pharmacare is negotiating partnerships to produce mpox vaccines at its facilities, as reported by CEO Stephen Saad. The World Health Organization declared mpox a global health emergency in August, with over 22,800 cases and 622 deaths reported across 13 African countries this year. Aspen seeks commitments for vaccine volumes and funding for technology transfer before proceeding with manufacturing.


With a significance score of 5.2, this news ranks in the top 1% of today's 29184 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: